Protein kinase C-ε is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperffision injury in primary rat neuronal cultures

被引:55
作者
Di-Capua, N
Sperling, O
Zoref-Shani, E [1 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Inst, IL-69978 Tel Aviv, Israel
关键词
adenosine; bisindolylmaleimide I; ischemia-reperfusion; protein kinase C translocation inhibitor peptide (epsilon V1-2); protein kinase C-epsilon; signal transduction pathway;
D O I
10.1046/j.1471-4159.2003.01563.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adenosine activates a signal transduction pathway (STP) in the heart and the brain, conferring protection against ischemia-reperfusion insult. Activation of protein kinase C (PKC), probably mainly PKC-epsilon, has been demonstrated to be part of the heart STP, but its role in the neuronal pathway is less clear. Here, we provide proof for the participation of PKC-epsilon in the neuronal adenosine-activated STP. Primary rat neuronal cultures were exposed to chemical ischemia by iodoacetate, followed by reperfusion. The cultured neurons were protected against this insult by activation of the adenosine mechanism, by N-6-(R)-phenylisopropyladenosine [R(-)-PIA], a specific A1 adenosine receptor agonist. Exposure of the cultures to bisindolylmaleimide I, a highly selective PKC inhibitor, abrogated the protection. The exposure of the cultures to R(-)-PIA was found to result in phosphorylation (activation) of PKC-epsilon. Furthermore, insertion into the cells of a specific peptide inhibitor of PKC-epsilon translocation (epsilonV1-2), also abrogated the protection conferred by R(-)-PIA. These results demonstrate that activation of PKC-epsilon is a vital step in the neuronal adenosine-activated STP.
引用
收藏
页码:409 / 412
页数:4
相关论文
共 20 条
[1]   Role of adenosine in delayed preconditioning of myocardium [J].
Baxter, GF .
CARDIOVASCULAR RESEARCH, 2002, 55 (03) :483-494
[2]   INVOLVEMENT OF PROTEIN-KINASE-C IN THE DELAYED CYTOPROTECTION FOLLOWING SUBLETHAL ISCHEMIA IN RABBIT MYOCARDIUM [J].
BAXTER, GF ;
GOMA, FM ;
YELLON, DM .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (02) :222-224
[3]   Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol [J].
Dutil, EM ;
Newton, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10697-10701
[4]  
HARA H, 1990, J CEREB BLOOD FLOW M, V10, P643
[5]  
Huang HM, 1999, J NEUROSCI RES, V56, P668, DOI 10.1002/(SICI)1097-4547(19990615)56:6<668::AID-JNR13>3.3.CO
[6]  
2-I
[7]   A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function [J].
Johnson, JA ;
Gray, MO ;
Chen, CH ;
MochlyRosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) :24962-24966
[8]  
LIU GS, 1997, J MOL CELL CARDIOL, V10, P1937
[9]   CHELERYTHRINE, A HIGHLY SELECTIVE PROTEIN-KINASE-C INHIBITOR, BLOCKS THE ANTIINFARCT EFFECT OF ISCHEMIC PRECONDITIONING IN RABBIT HEARTS [J].
LIU, YG ;
COHEN, MV ;
DOWNEY, JM .
CARDIOVASCULAR DRUGS AND THERAPY, 1994, 8 (06) :881-882
[10]   Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through ε protein kinase C [J].
Mackay, K ;
Mochly-Rosen, D .
CARDIOVASCULAR RESEARCH, 2001, 50 (01) :65-74